With 30 years of experience in CNS drug development we may offer you the fastest track from molecule to clinic. As a contract research organization we
-Support the development of new treatments for CNS diseases
-Alzheimer’s disease
-Parkinson’s disease
-Orphan neurodegenerative disorders
-Cerebrovascular diseases
-Psychiatric diseases
-Accelerate the drug/ treatment development by our profound knowledge of the requirements
-Pharmacology
-ADME
-Toxicology
-Regulatory issues (IND/ CTA)
- Clinical trials
-Optimize the chance of success, by knowing
-the most suitable preclinical models
-the most experienced and reliable service providers
-the competitive environment
- Support our clients in the best way by
-Designing most efficient individualized development plan
-Providing an outstanding network of KOLs in different fields of CNS diseases
- Fastest reaction time
-Competitive pricing
- International experience for more than 30 years
Company Details
- Employees
- 11
- Founded
- -
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- neuroscios.com
Neuroscios Gmbh Questions
Neuroscios Gmbh's website is neuroscios.com
Neuroscios Gmbh's LinkedIn profile is https://at.linkedin.com/company/neuroscios-gmbh
Neuroscios Gmbh has
11 employees.
View email and phone details for 11
employees at Neuroscios Gmbh.
Neuroscios Gmbh's industry is
Research Services
Neuroscios Gmbh's top competitors are
Blueskin Cro,
Das Kinderwunsch Institut Schenk,
Novotech,
Inferential.biostatistics,
Gl Pharma,
Octapharma Austria,
Nbcd,
Sanos Group,
Sanos Clinic,
Nordic Bioscience.
Neuroscios Gmbh's categories are Research Services
Neuroscios Gmbh's founding year is 2013
